PTLF (Petlife Pharmaceuticals) Other Stockholders Equity: $0.00 Mil (As of Feb. 2018)


What is Petlife Pharmaceuticals Other Stockholders Equity?

Petlife Pharmaceuticals PTLF Other Stockholders Equity is $0.00 Mil as of Feb. 2018.

Petlife Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Feb. 2018 was $0.00 Mil.

Petlife Pharmaceuticals's quarterly Other Stockholders Equity increased from Aug. 2017 ($0.00 Mil) to Nov. 2017 ($0.00 Mil) and increased from Nov. 2017 ($0.00 Mil) to Feb. 2018 ($0.00 Mil).

Petlife Pharmaceuticals's annual Other Stockholders Equity increased from Aug. 2015 ($-0.00 Mil) to Aug. 2016 ($0.00 Mil) but then declined from Aug. 2016 ($0.00 Mil) to Aug. 2017 ($0.00 Mil).

Petlife Pharmaceuticals Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Other Stockholders Equity Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00

Petlife Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Other Stockholders Equity of $0.00 Mil as of Feb. 2018. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Other Stockholders Equity too high?
Petlife Pharmaceuticals' current Other Stockholders Equity is $0.00 Mil.
How does Petlife Pharmaceuticals' Other Stockholders Equity compare to PCYN and YBAO?
Petlife Pharmaceuticals' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Other Stockholders Equity is $0.00 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.